載入...
Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer’s disease clinical trials
Preclinical Alzheimer’s disease (AD) clinical trials may require participants to learn if they meet biomarker enrollment criteria to enroll. To examine whether this requirement will impact trial recruitment, we presented 132 older community volunteers who self-reported normal cognition with one of t...
Na minha lista:
| 發表在: | Neurobiol Aging |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4773920/ https://ncbi.nlm.nih.gov/pubmed/26923411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2015.11.007 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|